David Gate (@dgatelab) 's Twitter Profile
David Gate

@dgatelab

Director, Abrams Research Center, Northwestern Neurology. The Gate lab studies the immune system in neurodegenerative diseases.

ID: 1177655065496014848

linkhttps://sites.northwestern.edu/gatelab/ calendar_today27-09-2019 18:43:52

346 Tweet

3,3K Followers

2,2K Following

David Gate (@dgatelab) 's Twitter Profile Photo

Excited to announce that we are recruiting at our new Neurogenomics Center at Northwestern! We are looking for passionate postdoc candidates to join our team. nature.com/naturecareers/…

Northwestern Medicine (@northwesternmed) 's Twitter Profile Photo

The team at Abrams Research Center on Neurogenomics, led by David Gate, is excited to explore their new lab! Using #ArtificialIntelligence, genetic research and global collaborations, they’re advancing Alzheimer’s disease research. #NMBetter

The team at Abrams Research Center on Neurogenomics, led by <a href="/DGateLab/">David Gate</a>, is excited to explore their new lab! Using #ArtificialIntelligence, genetic research and global collaborations, they’re advancing Alzheimer’s disease research. #NMBetter
Nature Medicine (@naturemedicine) 's Twitter Profile Photo

Spatial transcriptomics reveals distinct microglial mechanisms driving amyloid-β clearance in both passive and actively immunized #Alzheimer’s disease patients Northwestern Feinberg School of Medicine nature.com/articles/s4159…

Lynn van Olst (@lynnolst) 's Twitter Profile Photo

Excited to share our latest Nature Medicine study from our new center Abrams Research Center on Neurogenomics! 🧠✨ Using spatial transcriptomics & scRNA-seq, we uncover how Aβ-targeting immunotherapies shape microglial responses in AD patient brains. A thread with our key findings is below! 🧵(1/15)

Abrams Research Center on Neurogenomics (@arc_neuro) 's Twitter Profile Photo

ć‚¢ćƒ«ćƒ„ćƒć‚¤ćƒžćƒ¼ē—…ć®ę²»ē™‚ćÆč„³č‡Ŗčŗ«ć®ć‚ÆćƒŖćƒ¼ćƒ³ć‚¢ćƒƒćƒ—ć‚Æćƒ«ćƒ¼ć«ć‚ć‚‹ć‹ć‚‚ć—ć‚Œć¾ć›ć‚“ nipponese.news/%e3%82%a2%e3%8…

David Gate (@dgatelab) 's Twitter Profile Photo

This video describes the findings from our recent study conducted at ⁦Abrams Research Center on Neurogenomics⁩. In the video, lead author ⁦Lynn van Olst⁩ and I discuss the findings and their implications for Alzheimer’s disease. youtu.be/pnRzktJRWAo

David Gate (@dgatelab) 's Twitter Profile Photo

This Northwestern Breakthroughs podcast nicely encapsulates our study. The host does a great job leading the discussion for the lay audience to digest our work. I hope this allows people to better understand the results and impact of this study. youtu.be/bZrdwGQ_Ok0

David Gate (@dgatelab) 's Twitter Profile Photo

It’s quite an experience to have some of your favorite labs like ⁦The Colonna Lab⁩ and ⁦Haass lab⁩ comment on your lab’s research. Great reporting by Alzforum! alzforum.org/news/research-…

Hamilton Oh (@hammy_oh) 's Twitter Profile Photo

I am excited to present our new study out in Nature Medicine where we discover a novel synaptic protein biomarker to predict if and when someone will get Alzheimer’s disease dementia. Part 2/3 from my PhD work in the Tony Wyss-Coray lab. 🧵1/12 Full study šŸ”—: nature.com/articles/s4159…

Tempus (@tempusai) 's Twitter Profile Photo

We are proud to announce a collaboration with Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine to harness AI for rapid discovery and innovation in Alzheimer’s disease research. Using Lens, the Center and Tempus teams will work together to uncover genomic patterns

We are proud to announce a collaboration with <a href="/ARC_Neuro/">Abrams Research Center on Neurogenomics</a> at Northwestern University Feinberg School of Medicine to harness AI for rapid discovery and innovation in Alzheimer’s disease research. Using Lens, the Center and Tempus teams will work together to uncover genomic patterns
FranƧois Chollet (@fchollet) 's Twitter Profile Photo

Key to research success: ambition in vision, but pragmatism in execution. You must be guided by a long-term, ambitious goal that addresses a fundamental problem, rather than chasing incremental gains on established benchmarks. Yet, your progress should be grounded by tractable